IRCT201105096309N1Completed未知
Effect of intravenous magnesium sulfate on blood complement,quantitative CRP level and leukocytes count in patient with acute myocardial infarction who treated with streptokinase
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 44
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Patients with acute myocardial infarction who treated with streptokinase be enrolled in the study
- •Exclusion criteria are:cardiogenic shock,systolic blood pressure<90,AV block grade2&3,illiac resection,renal failure,collagen vascular diseases,alcohol&drug abuse,chemotherapy and consumption of immunosuppresive drugs during a past year
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 2
The effect of Mg on the cardiac biomarker proBNPAtherosclerotic heart disease.Atherosclerotic heart diseaseIRCT201205069650N1Anesthesiology Research Center, Shahid Beheshtil Universityof medical sciences60
Completed
Phase 3
The effect of intravenous magnesium sulfate in the treatment of patients with chronic obstructive pulmonary diseaseChronic Obstructive Pulmonary Disease.Chronic obstructive pulmonary disease with acute exacerbation, unspecifiedJ44.1IRCT2014111519962N1Vice Chanceller for research of Mashhad University of Medical Sciences90
Completed
Not Applicable
Effect of magnesium sulphate on postoperative paiIRCT201201088645N1Ahvaz Jondishapour University of Medical Sciences100
Not yet recruiting
Phase 3
Benefit of injection magnesium sulphate in patient with increased shortness of breath in COPD patientsCTRI/2024/05/066775All India Institute of Medical Sciences Bhubaneswar
Recruiting
Phase 3
The effect of intravenous magnesium sulfate as a complementary therapy to COPDIRCT20150315021480N8Vice chancellor for research of Mazandaran University of Medical Sciences100